ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In agreement with previous reports on CML [28], we show that FTY720 has a modest negative impact on the proliferation of BCR:ABL + KMT2A-wt- leukemic cell line K562 and promotes cell death.